Julio Montaner - Concepedia

Author

Julio Montaner

Also Known As

Anthony Wu, Anton Pozniak, Bruce R. Schackman, David Moore, Dimitra Panagiotoglou, Gerardo Alvarez-Uria, Gregory Kirk, J Montaner, J S G Montaner, J S Montaner

937

Publications

48.8K

Citations

101

H-Index

297

Concepts

All Affiliations

University of British Columbia St. Paul's Hospital AIDS Vancouver Simon Fraser University St. Paul's Hospital

About

Julio Montaner is an author at University of British Columbia specializing in public health, medicine, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	31	53	3.3K
2	Education	7	7	285
3	Business	4	4	177
4	Law	4	4	169
5	Engineering	1	1	23

Julio Montaner

555

Publications

40.7K

Citations

H-Index

Page 1

	Year	Citations
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡ Richard K. Sterling, Eduardo Lissen, Nathan Clumeck, Hepatology	2006	4.6K
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study Julio Montaner, Viviane D. Lima, Rolando Barrios, The Lancet Preventive MedicineEpidemiological OutcomeTreatment And PreventionBritish ColumbiaNew Hiv Diagnoses	2010	777
A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients Julio Montaner, David A. Cooper, Stefano Vella, JAMA	1998	771
Needle exchange is not enough Steffanie A. Strathdee, David M. Patrick, Sue Currie, AIDS Sexual HealthSubstance AbuseSubstance UsePreventive MedicineTreatment And Prevention	1997	663
Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients Hélène C. F. Côté, Zabrina L. Brumme, Kevin J.P. Craib, New England Journal of Medicine	2002	572
Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada Wendy Zhang, Nadia O’Brien, Jamie I. Forrest, PLoS ONE	2012	541
Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study Brandon D. L. Marshall, M‐J Milloy, Evan Wood, The Lancet Harm ReductionHealth PolicyPatient SafetyOpioid OverdoseOverdose Mortality	2011	476
Predictors of HIV Drug‐Resistance Mutations in a Large Antiretroviral‐Naive Cohort Initiating Triple Antiretroviral Therapy P. Richard Harrigan, Robert S. Hogg, Winnie Dong, The Journal of Infectious Diseases	2005	433
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up Robert S. Hogg, Katherine Heath, David R. Bangsberg, AIDS	2002	426
Adverse effects of antiretroviral therapy for HIV infection. Valentina Montessori, Natasha Press, Marianne Harris, PubMed	2004	359

Page 1